{{Rsnum
|rsid=1464602
|Gene=NR1I2
|Chromosome=3
|position=119807525
|Orientation=minus
|GMAF=0.4229
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NR1I2
}}{{PharmGKB
|RSID=rs1464602
|Name_s=g.275A>G
|Gene_s=NR1I2
|Feature=
|Evidence=PubMed ID:17050801
|Annotation=risk allele: G; part of haplotype g.252A>G (rs1464603), g.275A>G (rs1464602), and g.4760G>A ; AF364606 significantly (P < .05) associated with oral midazolam clearance in the African American subpopulation (n = 14) but not in European Americans (n = 9).
|Drugs=midazolam
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA165363642
}}